ArticleCurrent issues in molecular biology2025

Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen.

Richard E KastPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.